Cyclosporin-A therapy in severe uveitis of Behcet's disease

Acta Ophthalmologica Scandinavica

Volumn 76, Issue 1, 1998, Pages 96-99

  Süllü, Yüksel ^a   Öge, Ihsan ^a   Erkan, Dilek ^a   Aritürk, Nurşen ^a   Mohajeri, Farshid ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Behcet's disease; Cyclosporine A; Retinal vasculitis; Uveitis

Indexed keywords

COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; CYTOTOXIC AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; FATIGUE; FEMALE; FOLLOW UP; HIRSUTISM; HUMAN; HYPERESTHESIA; MALE; NAUSEA; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PARESTHESIA; PRIORITY JOURNAL; UVEITIS; VISUAL ACUITY;

EID: 0345734110     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0420.1998.760118.x     Document Type: Article

References (16)

1. Atmaca L, Batioǧlu F (1994): The efficacy of cyclosporin A in the treatment of Behçet's disease. Ophthalmic Surg 25: 321-327.
2. BenEzra D, Cohen E (1986): Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 70: 589-592.
3. Binder AI, Graham EM, Sanders MD, Dinning W, James DG & Denman AM (1987): Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol 26: 285-291.
4. Chavis PS, Antonios SR & Tabbara KF (1992): Cyclosporine effects on optic nerve and retinal vasculitis in Behçets disease. Doc Ophthalmol 1992; 80: 133-142.
5. Diaz-Llopis M, Cervera M & Menezo JL (1990): Cyclosporin A treatment of Behçet's disease: a long-term study. Curr Eye Res 9: 19-23.
6. Dumonde DC, Kasp-Grochowska E, Graham E, Sanders MD, Faure JP, Kozak YD & Tuyen VV (1982): Anti-retinal autoimmunity and circulating immune complexes in patients with retinal vasculitis. Lancet 2: 787-792.
7. Hogan JM, Kimura SJ, & Thygesson P (1959): Signs and symptoms of uveitis: I. Anterior Uveitis. Am J Ophthalmol 47: 155-170.
8. International Study Group for Behçet's Disease (1990): Criteria for diagnosis of Behçet's disease. Lancet 335: 1078-1080.
9. Kimura SJ, Thygeson P & Hogan MJ (1959): Signs and symptoms of uveitis: Classification of the posterior manifestations of uveitis. Am J Ophthalmol 47: 171-176.
10. Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M & Inaba G (1989): Double-Masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet 1(8647): 1093-1096.
11. Michelson JB (1993): Diffuse uveitis. Ophthalmol Clin North Am 6: 55-68.
12. Müftüǒglu AÜ, Pazarli H, Yurdakul S, Yazici H, Ülkü BY, Tüzün Y, Serdaroǧlu S, Altuǧ E, Bahçecioǧlu H & Güngen G (1987): Short term cyclosporin A treatment of Behçet's disease. Br J Ophthalmol 71: 387-390.
13. Nussenblatt RB, Palestina AG & Chan CC (1983): Cyclosporin a therapy in the treatment of intraocular inflammatory disease resistant to systemic corticosteroids and cytotoxic agents. Am J Ophthalmol 96: 275-282.
14. Nussenblat RB, Palestine AG, Chan CC, Mochizuki M & Yancey K (1985): Effectiveness of cyclesporin therapy for Behçet s disease. Arthritis Rheum 84: 671-679.
15. Palestine AG, Austin HA III, Balow JE, Antonovych TT, Sabnis SG, Preuss HG, & Nussenblatt RB (1986): Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med 314: 1293-1298.
16. Whitcup SM, Salvo EC Jr & Nussenblatt RB (1994): Combined cyclosporine and cortico-steroid therapy for sight-threatening uveitis in Behçet's disease. Am J Ophthalmol 118: 39-45.